Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMR
· Real-Time Price · USD
4.00
-0.26 (-6.10%)
At close: Aug 15, 2025, 3:59 PM
4.02
0.63%
After-hours: Aug 15, 2025, 07:34 PM EDT
Larimar Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.17 | -2.14 | -6.74 | -6.08 | -6.82 | -3.84 | -4.78 | -4.11 | -9.18 | -2.95 | -2.19 | -1.04 | -2.06 | -5.42 | -3.14 | -3.11 | -4.83 |
PEG Ratio | 0.55 | -0.02 | 0.23 | -0.23 | 0.68 | -0.09 | -0.45 | -0.07 | 0.14 | 0.54 | 0.10 | 0.25 | 1.03 | 0.12 | -0.19 | -0.79 | 0.33 |
PS Ratio | n/a | 1.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.95 | 1.44 | 2.11 | 2.49 | 1.73 | 2.44 | 1.87 | 1.37 | 1.87 | 0.89 | 0.60 | 0.72 | 1.30 | 3.07 | 2.93 | 2.33 | 2.97 |
P/FCF Ratio | -5.17 | -11.23 | -16.98 | -36.86 | -38.37 | -21.01 | -18.85 | -18.66 | -26.34 | -14.85 | -12.1 | -4.74 | -9.86 | -24.96 | -16.88 | -14.53 | -20.86 |
P/OCF Ratio | -5.18 | -11.32 | -17.03 | -37.58 | -38.37 | -21.38 | -18.85 | -18.66 | -26.34 | -14.85 | -12.1 | -4.8 | -9.86 | -24.99 | -17.29 | -14.57 | -20.86 |
OCF/S Ratio | n/a | -90.52 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.11 | 0.10 | 0.09 | 0.09 | 0.09 | 0.08 |
Quick Ratio | 7.48 | 8.02 | 13.10 | 10.93 | 17.99 | 9.49 | 15.02 | 14.68 | 14.20 | 11.28 | 13.50 | 7.35 | 7.31 | 8.19 | 7.88 | 9.63 | 10.28 |
Current Ratio | 7.48 | 8.02 | 13.10 | 10.93 | 17.99 | 9.49 | 15.02 | 14.64 | 14.17 | 11.28 | 13.50 | 7.35 | 7.31 | 8.16 | 7.88 | 9.63 | 10.28 |
Asset Turnover | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -158.7 | n/a | n/a | n/a | n/a |
Return on Equity | -0.2 | -0.17 | -0.08 | -0.1 | -0.06 | -0.16 | -0.1 | -0.08 | -0.05 | -0.08 | -0.07 | -0.17 | -0.16 | -0.14 | -0.23 | -0.19 | -0.15 |
Return on Assets | -0.17 | -0.14 | -0.07 | -0.09 | -0.06 | -0.14 | -0.09 | -0.07 | -0.05 | -0.07 | -0.06 | -0.14 | -0.13 | -0.12 | -0.19 | -0.16 | -0.13 |
Return on Invested Capital | -0.21 | -0.18 | -0.09 | -0.11 | -0.07 | -0.16 | -0.1 | -0.09 | -0.06 | -0.08 | -0.07 | -0.15 | -0.14 | -0.13 | -0.21 | -0.17 | -0.14 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -119.6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -119.6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -129.85 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -129.53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |